{
}
The Global Uveitis Treatment market is projected to grow from USD 725 million in 2024 to USD 1.28 billion by 2032, with a CAGR of 8.5%. The study covers various treatment types, including corticosteroids and biologic agents, and offers customization options for regional and application-specific analysis. Key players include Novartis, Pfizer, and AbbVie, with North America leading the market and Asia-Pacific identified as the fastest-growing region.
Novartis is closing MorphoSys sites in Munich and Boston, resulting in approximately 330 layoffs, as part of its integration strategy following the €2.7 billion acquisition earlier this year. The decision aligns with a focus on prioritizing R&D programs, particularly the delayed approval pathway for the oncology candidate pelabresib. This trend of post-acquisition job cuts has been observed across several major pharma companies in recent years.
A consensus is forming that the Federal Reserve should hold off on further interest rate cuts after a 25-basis-point move. Wall Street saw mixed results, with the Dow closing lower for the ninth consecutive session, a first since 1978. In corporate news, Microsoft significantly increased its Nvidia chip purchases, while Starbucks union workers authorized a strike. Morgan Stanley named Disney a top pick, and Salesforce announced plans to double its hiring for AI customer service agents.
Teva and Sanofi's experimental drug, duvakitug, demonstrated significant efficacy in a Phase 2 trial for inflammatory bowel disease, with around 50% of ulcerative colitis patients and 48% of Crohn’s disease patients showing symptom resolution compared to placebo. The companies plan to advance to late-stage development, highlighting duvakitug's potential as a leading treatment in a competitive market. Following the promising results, Teva's shares surged nearly 20%, while Sanofi's rose by almost 5%.
The Global Bisoprolol Fumarate market is projected to grow from USD 1.3 billion in 2023 to USD 2.0 billion by 2032, with a CAGR of 7%. This medication, primarily used for hypertension and heart-related conditions, is expected to see increased demand driven by regulatory changes and market dynamics across various regions, particularly in Europe and Asia-Pacific. Key players include Merck, Pfizer, and Novartis, with a focus on understanding market trends and competitive strategies.
AbbVie's schizophrenia drug emraclidine failed two mid-phase trials, performing no better than placebo, resulting in a $40 billion market cap loss for the company. This setback follows the recent approval of Bristol Myers Squibb's Cobenfy, the first new schizophrenia drug in decades, which boosted BMS's share price by 12%. The failure raises concerns for other companies developing similar drugs in the same class.
The Breakthrough Therapies Market is projected to grow from USD 150.6 billion in 2024 to USD 287.5 billion by 2029, achieving a CAGR of 13.80%. The report analyzes risks, benefits, and competitive strategies related to breakthrough therapy designation across various therapeutic areas, including oncology and rare diseases, while profiling key market players and trends.
The global Topical Corticosteroids market, valued at approximately US$ 4.12 billion in 2022, is projected to grow at a CAGR of 4.36% through 2030. The report provides an extensive analysis of market dynamics, competitive landscape, and consumption trends, highlighting key players like GlaxoSmithKline and Merck & Co. It also explores opportunities for growth driven by increasing demand across various industries, while addressing challenges such as supply chain disruptions and changing consumer preferences.
The preventive healthcare technologies and services market is projected to grow from $259.84 billion in 2023 to $541.36 billion by 2028, driven by an aging population and advancements in digital health. Key players are innovating with advanced preventative care programs, such as WELL Longevity+, which integrates AI and diagnostic imaging to enhance early intervention strategies.
The Growth Factors Market is influenced by strategic mergers, consumer shifts towards sustainability, and advancements in data analytics. Key challenges include cybersecurity risks and skilled labor shortages, while opportunities lie in personalized e-commerce and renewable energy solutions. Major players like Johnson & Johnson and Thermo Fisher Scientific are shaping the competitive landscape through innovation and market expansion.
Merck & Co., Inc.
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
global uveitis treatment market poised for significant growth by 2032
Pfizer Inc.
Bayer AG
Novartis AG
Regeneron Pharmaceuticals, Inc.
Merck & Co., Inc.
CIPLA LTD
Lupin Limited
Hoffmann-La Roche AG
Bausch Health Companies Inc.
BIOGEN
ABBVIE
Alimera Sciences Inc.
SAU
ISR
FRA
RUS
DEU
TWN
ARG
ARE
AUT
TUR
SGP
NZL
CHL
USA
BRA
CAN
ITA
JPN
IDN
GBR
ESP
IND
MYS
COL
AUS
THA
EGY
VNM
KOR
PHL
CHN
ZAF
MEX
Nidhi Bhavsar
Show more
20:41 19.12.2024
Novartis to close MorphoSys sites and lay off 330 employees
Euro
Sanofi
GSK plc
Gilead Sciences, Inc.
Incyte Corp
Novartis AG
Immunomedics Inc.
Horizon Therapeutics Public Lim
Bellus Health Inc.
Merck & Co., Inc.
Bristol-Myers Squibb Co
Amgen Inc.
MorphoSys AG
USA
DEU
CHE
Vas Narasimhan
Show more
15:47 19.12.2024
federal reserve interest rate decision impacts mixed wall street performance
Alphabet Inc.
NVIDIA Corporation
Novo Nordisk A/S
Eli Lilly and Company
DuPont de Nemours, Inc.
Microsoft Corporation
Merck & Co., Inc.
Salesforce, Inc.
Starbucks Corp
Citizens, Inc.
Elon Musk
Donald Trump
Robert F. Kennedy Jr.
Brian Niccol
Show more
15:33 18.12.2024
duvakitug shows promise as best in class for inflammatory bowel disease
01:00 17.12.2024
global bisoprolol fumarate market poised for significant growth through 2032
United States Dollar
Merck & Co., Inc.
Amgen Inc.
Alkem Laboratories Limited
Mylan Pharmaceuticals Inc.
Aurobindo Pharma Limited
Teva Pharmaceutical Industries Ltd
Dr. Reddy's Laboratories Limited
Glenmark Pharmaceuticals Limited
CIPLA LTD
Sandoz Group AG
Pfizer Inc.
Bayer AG
Hikma Pharmaceuticals PLC
AstraZeneca PLC
Novartis AG
Torrent Pharmaceuticals Limited
Sanofi
IND
ROU
BEL
HUN
DNK
POL
IDN
SGP
ARE
BRA
ZAF
FRA
THA
MEX
CZE
GBR
CHL
AUT
SAU
SWE
NOR
NLD
USA
ARG
MYS
SVK
CAN
NZL
LKA
JPN
DEU
RUS
KOR
CHN
VNM
Nidhi Bhavsar
Show more
13:09 16.12.2024
setbacks in drug development impact schizophrenia and oncology markets
Arcus Biosciences, Inc.
Hoffmann-La Roche AG
Gilead Sciences, Inc.
Biohaven Ltd.
Merck & Co., Inc.
Genentech
Cassava Sciences, Inc.
ABBVIE
Bristol-Myers Squibb Co
BioAge Labs, Inc.
USA
Jean Rochefort
Show more
01:00 16.12.2024
breakthrough therapy designation market projected to reach 287.5 billion by 2029
United States Dollar
Bristol-Myers Squibb Co
Merck & Co., Inc.
AstraZeneca PLC
F. Hoffmann-La Roche Ltd.
Novartis AG
Show more
17:02 13.12.2024
topical corticosteroids market poised for growth with emerging opportunities and trends
Merck & Co., Inc.
AstraZeneca PLC
Almirall S.A. A
Bristol-Myers Squibb Company
Glaxosmithkline plc
Leo Pharma AB
Bausch Health Companies Inc.
IND
GBR
CAN
SAU
JPN
BRA
DEU
FRA
MEX
CHN
USA
Viju Shah
Alice Mutum
Show more
11:04 13.12.2024
preventive healthcare technologies market poised for significant growth by 2028
McKesson Corporation
Alere Inc.
Omnicell Inc
Medtronic plc
Merck & Co., Inc.
Walgreens Boots Alliance Inc
Quest Diagnostics Incorporated
Cerner Corporation
Glaxosmithkline plc
Myriad Genetics Inc
Healthways Inc.
Teladoc Health Inc
Pfizer Inc.
ModivCare Inc.
Vocera Communications Inc.
Novartis AG
Tivity Health Inc.
Sanofi SA
Change Healthcare Inc.
Allscripts Healthcare Solutions Inc
GRAIL Inc
Show more
11:23 09.12.2024
Growth Factors Market Insights Opportunities and Challenges in Emerging Industries
Lonza Group AG
Sartorius AG
Merck & Co., Inc.
Thermo Fisher Scientific Inc.
Johnson & Johnson Services Inc.
F. Hoffmann-La Roche SA
Show more
14:46 06.12.2024
Trending
Subcategory
Corporate News
Industry Trends
Startups & Entrepreneurship
Global Trade Developments
Stock Market Updates
Industry Mergers & Acquisitions
Inflation and Monetary Impact
Private Equity Deals
Supply Chain Management
Government Economic Policies
Cryptocurrency Trends
Retail and Consumer Goods
Fintech Startups
Workplace Trends
Central Bank Actions
Central Banks and Digital Currencies
Venture Capital Investments
CEO Changes
Finance Mergers & Acquisitions
Energy Sector Developments
Countries:
Companies:
Apple Inc.
Foxconn Technology Co., Ltd.
NVIDIA Corporation
Nasdaq 100 Jun 25
Tencent Holdings Ltd
Google Inc.
NIO Inc.
Nikkei 225
Grab2Go AS
OLA ELECTRIC MOBILITY LTD
Boeing Co
Airbus SE
Amazon.com, Inc.
Oracle AI USD
AppLovin Corp.
Tesmec S.p.A.
DeepSeek R1 USD
LG Electronics Inc.
Tesla, Inc.
MARA Holdings, Inc.
Currencies:
United States Dollar
Euro
Indian Rupee
Chinese Yuan
Japanese Yen
United Arab Emirates Dirham
New Taiwan Dollar
Indonesian Rupiah
Saudi Riyal
Offshore Chinese Yuan
Egyptian Pound
Hong Kong Dollar
Malaysian Ringgit
Filipino Peso
West African CFA Franc
South Korean Won
Thai Baht
Mexican Peso
Croatian Kuna
Bahraini Dinar
People: